An expert review report released by the Food and Drug Administration (FDA) Monday raised doubts as to whether the vaccine developed by Taiwan-based United Biomedical Inc. (UBI) Asia offers sufficient protection against COVID-19 variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Thousands of Filipinos attend Independence Day events in New Taipei
06/16/2024 06:06 PM - Sports
Taiwan clinches full archery qualification for Paris Olympics
06/16/2024 04:26 PM - Politics
Whampoa spirit follows where ROC goes: Lai at centennial
06/16/2024 02:58 PM - Society
Temperature high hits 36.6°C in Taitung
06/16/2024 02:16 PM - Society
Taiwan headline news
06/16/2024 12:04 PM